Understanding social interaction in individuals with schizophrenia
Study of Multimodal Intra- and Interpersonal Synchronizations in Social Interaction in Individuals with a Diagnosis of Schizophrenia.
This study is trying to see how people with schizophrenia communicate and interact with others by looking at their responses during conversations and completing some tests.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT06484387 on ClinicalTrials.gov |
What this trial studies
This study aims to identify deficits in intra- and interpersonal multimodal synchronizations during social interactions in individuals diagnosed with schizophrenia. Participants will engage in various conversational tasks with an interaction partner, followed by completing questionnaires and neuropsychological tests. The study focuses on how auditory and visual channels contribute to communication and social feedback. By analyzing these interactions, researchers hope to gain insights into the social functioning of individuals with schizophrenia.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with schizophrenia who can read, speak, and understand French.
Not a fit: Patients with a history of neurological conditions or substance use may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of social communication deficits in schizophrenia, potentially leading to improved therapeutic strategies.
How similar studies have performed: Previous studies have indicated the importance of multimodal synchronizations in social interactions, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Individuals with a diagnosis of schizophrenia : Inclusion Criteria: * diagnosis of schizophrenia according to the DSM-V * being able to read, speak and understand french * giving eclaired consent Exclusion Criteria: * history of head trauma * history of neurological conditions (epilespsy, multiple sclerosis, parkinson's disease, amyotrophic lateral sclerosis, huntington's disease, stroke) * substance use * pregnant women Healthy controls : Inclusion Criteria: * being able to read, speak and understand french * giving eclaired consent Exclusion Criteria: * diagnosis of psychosis * history of head trauma * history of neurological conditions (epilespsy, multiple sclerosis, parkinson's disease, amyotrophic lateral sclerosis, huntington's disease, stroke) * substance use * pregnant women
Where this trial is running
Montpellier
- Montpellier University Hospital — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: Delphine Capdevielle, Pr
- Email: d-capdevielle@chu-montpellier.fr
- Phone: 0467339702
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.